Can patients who have recovered from COVID-19 continue to have detectable SARS-CoV-2 RNA in upper respiratory specimens?

Can patients who have recovered from COVID-19 continue to have detectable SARS-CoV-2 RNA in upper respiratory specimens?

• Patients who have recovered from COVID-19 can continue to have detectable SARS-CoV-2 RNA in upper respiratory specimens for up to 3 months after illness onset in concentrations considerably lower than during illness; however, replication-competent virus has not been reliably recovered and infectiousness is unlikely.

See also  What does SBMA insurance stand for?